Tutogen Medical pulls itself back on track and attracts Zimmer interest
This article was originally published in Clinica
Executive Summary
Tutogen Medical's share price soared 26% to hit $4.90 - the highest it has reached over the last 12 months - during trading on Monday (March 13) after the company revealed it has been approached by Zimmer to discuss "potential strategic transactions". These include, but are not limited to, the orthopaedic device maker upping its stake in Tutogen or buying the entire firm.